Treace Medical Concepts (TMCI) Preferred Dividend Payments (2020 - 2021)

Treace Medical Concepts (TMCI) posted Preferred Dividend Payments of $39000.0 for Q2 2021, down 75.32% on a QoQ basis from $158000.0 in Q1 2021, and down 75.47% year-over-year from $159000.0 in Q2 2020.

Treace Medical Concepts (TMCI) Preferred Dividend Payments (2020 - 2021) Analysis & Trends

Treace Medical Concepts' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $39000.0 for Q2 2021.

  • Quarterly Preferred Dividend Payments fell 75.47% year-over-year to $39000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2022 was $39000.0 (down 92.49% YoY) and the FY2021 annual result came in at $196000.0, down 69.38% from the prior year.
  • Preferred Dividend Payments was $39000.0 for Q2 2021 at Treace Medical Concepts, down from $158000.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $161000.0 in Q3 2020 and bottomed at $39000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Treace Medical Concepts 261.60 Mn 209.75 Mn 37.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 39,000.00
Mar 31, 2021 158,000.00
Dec 31, 2020 161,000.00
Sep 30, 2020 161,000.00
Jun 30, 2020 159,000.00
Mar 31, 2020 158,000.00